Contralateral prophylactic mastectomy in the setting of breast cancer diagnosis and their insurance coverage in the United States.

The coverage of CPM in the United States varies from complete denial to unrestricted approval. This may be due to conflicting reports in the literature as to the utility of the procedure. The decision to undergo this procedure must be taken with thoughtful consideration and the support of a multidisciplinary approach.